Post-exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV*

被引:3
|
作者
Gantner, P. [1 ,2 ]
Allavena, C. [3 ]
Duvivier, C. [4 ,5 ,6 ,7 ]
Cabie, A. [8 ]
Reynes, J. [9 ]
Makinson, A. [9 ]
Ravaux, I [10 ]
Bregigeon, S. [11 ]
Cotte, L. [12 ]
Rey, D. [13 ]
机构
[1] Strasbourg Univ Hosp, Mol Virol Dept, 3 Rue Koeberle, F-67000 Strasbourg, France
[2] Strasbourg Univ, INSERM, UMR S U1109, Strasbourg, France
[3] Hop Hotel Dieu, Infect Dis Dept, Nantes, France
[4] Hop Necker Enfants Malad, AP HP, Necker Pasteur Infectiol Ctr, Infect Dis Dept, Paris, France
[5] Pasteur Inst, Med Ctr, Necker Pasteur Infectiol Ctr, Paris, France
[6] Paris Descartes Univ, EA7327, Sorbonne Paris Cite, Paris, France
[7] IHU Imagine, Paris, France
[8] Antilles Univ, CHU Martinique, EA 4537, Infect Dis Dept,Inserm CIC1424, Fort De France, Martinique, France
[9] CHU Montpellier, Inserm U1175, Infect Dis Dept, Montpellier, France
[10] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, Marseille, France
[11] CHU St Marguerite, AP HM, Clin Immunohematol Dept, Marseille, France
[12] Croix Rousse Hosp, Infect Dis Dept, Lyon, France
[13] Strasbourg Univ Hosp, HIV Infect Care Ctr, Le Trait Union, Strasbourg, France
关键词
condom use; HIV; post-exposure prophylaxis; sexual exposure; treatment discontinuation; TENOFOVIR; MEN; TOLERABILITY;
D O I
10.1111/hiv.12880
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives Post-exposure prophylaxis (PEP) care remains a challenge for individuals with potential sexual exposure to HIV in terms of PEP completion and ongoing risk behaviours. Methods A retrospective analysis was carried out on data from the French Dat'AIDS prevention cohort (NCT03795376) for individuals evaluated for PEP between 2004 and 2017. A multivariable analysis was performed of predictors of both PEP completion and condom use [odds ratios (ORs)] and their associated probabilities (P, withP > 95% being clinically relevant). Results Overall, 29 060 sexual exposures to HIV were evaluated for PEP [36% in men who have sex with men (MSM) and 64% in heterosexuals]. Overall, 12 different PEP regimens were offered in 19 240 cases (46%). Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) was the preferred backbone (n = 14 304; 74%). We observed a shift from boosted protease inhibitor-based regimens to nonnucleoside reverse transcriptase inhibitor- or integrase inhibitor-based regimens in recent years. Overall, 20% of PEP prescriptions were prematurely discontinued. Older age, MSM, intercourse with a sex worker, rape and intercourse with a known HIV-infected source patient were factors associated with increased rates of PEP completion (OR > 1;P > 98%). None of the 12 PEP regimens was associated with premature discontinuation. We also found 12 774 cases of unprotected sexual intercourse (48%). Condom use decreased (OR P > 99%) with the year of exposure, and was lower in MSM and rape victims. Condom use increased (OR > 1,P > 99%) with age, and was higher in those who had intercourse with a sex worker or with a female partner and in those with knowledge of the partner's HIV status. Conclusions We provide new insights into how rates of condom use and PEP completion might be improved in those receiving PEP by targeting certain groups of individuals for interventions. In particular, youth and MSM at risk should be linked in a prevention-to-care continuum.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 50 条
  • [1] Post-exposure prophylaxis for sexual exposure to HIV
    Pozniak, A
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (01) : 39 - 40
  • [2] UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure
    Fisher, M
    Benn, P
    Evans, B
    Pozniak, A
    Jones, M
    MacLean, S
    Davidson, O
    Summerside, J
    Hawkins, D
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (02) : 81 - 92
  • [3] Occupational exposure to HIV and the use of post-exposure prophylaxis
    Hamlyn, Elizabeth
    Easterbrook, Philippa
    OCCUPATIONAL MEDICINE-OXFORD, 2007, 57 (05): : 329 - 336
  • [4] UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015
    Cresswell, Fiona
    Waters, Laura
    Briggs, Eleanor
    Fox, Julie
    Harbottle, Justin
    Hawkins, David
    Murchie, Martin
    Radcliffe, Keith
    Rafferty, Paul
    Rodger, Alison
    Fisher, Martin
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (09) : 713 - 738
  • [5] UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011)
    Benn, P.
    Fisher, M.
    Kulasegaram, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (12) : 695 - 708
  • [7] HIV post-exposure prophylaxis after sexual assault
    Crossley, J
    EMERGENCY MEDICINE JOURNAL, 2004, 21 (04) : 403 - 403
  • [8] Post-exposure prophylaxis for HIV
    Gathiram, V
    SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (04): : 346 - +
  • [9] Post-exposure prophylaxis for HIV
    Gerberding, JL
    Katz, MH
    ANTIVIRAL CHEMOTHERAPY 5: NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, 1999, 458 : 213 - 222
  • [10] Enhancing the potential benefits of HIV post-exposure prophylaxis
    Roland, Michelle E.
    AIDS, 2006, 20 (14) : 1889 - 1890